3 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 3 |
| Phase 2 | 1 | Unknown 1 |
Follow AIDS: new trials by email Literature Review of AIDS trials Research Report on AIDS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Efficacy and Safety Study of shRNA-modified CD34+ Cells in HIV-infected Patients. shRNA-modified CD34+ cells, Low dose busulfan preconditioning, Busulfan preconditioning - HIV Infections, AIDS | Phase 1 | Unknown | Shanghai Public Health Clinical Center | 6 | 2018-02-27 | 2020-02-19 |
| Evaluation on Seropositive Patients of a Synthetic Vaccine Targeting the HIV Tat Protein Tat Oyi - AIDS | Phase 1 / Phase 2 | Unknown | BIOSANTECH | 50 | 2013-02-01 | 2016-02-10 |
| Bioequivalence Study of Pediatric Formulations to Treat HIV Infection Epivir®, Retrovir® and Viramune®, Lamivudine, Zidovudine and nevirapine, Lamivudine, zidovudine, nevirapine - HIV, AIDS | Phase 1 | Unknown | Elim Pediatric Pharmaceuticals Inc. | 24 | 2010-10-01 | 2011-11-10 |
Acquired Immunodeficiency Syndrome (3) · HIV Infections (1)
Blood-Borne Infections (3) · Communicable Diseases (3) · Genital Diseases (3) · Immune System Diseases (3) · Immunologic Deficiency Syndromes (3) · Infections (3) · Lentivirus Infections (3) · RNA Virus Infections (3) · Retroviridae Infections (3) · Sexually Transmitted Diseases (3) · Sexually Transmitted Diseases, Viral (3) · Slow Virus Diseases (3) · Urogenital Diseases (3) · Virus Diseases (3) · HIV Infections (2)
Busulfan (1) · Lamivudine (1) · Nevirapine (1) · Zidovudine (1)
BIOSANTECH (1) · Elim Pediatric Pharmaceuticals Inc. (1) · Shanghai Public Health Clinical Center (1)
China (1) · France (1) · Nigeria (1)
Daniel A Gbadero, MD (1) · Hongzhou Lu, Ph.D (1) · Isabelle Ravaux, MD (1) · Moji C Adeyeye, Ph.D (1)